HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis.

AbstractPURPOSE:
Pericytes play a specialized role in regulating angiogenesis and vascular function by providing vascular stability and controlling endothelial cell proliferation. Disorders in pericyte function and pericyte-endothelial interaction have been observed in several disease states including tumor angiogenesis and diabetic microangiopathy. In ischemic retinal disease, hypoxia is a potent driver of retinal angiogenesis. This study investigated the effects of hypoxia on retinal pericyte gene expression, and demonstrates a role in angiogenesis regulation for the hypoxia driven gene, chordin-like 1 (CHL-1).
METHODS:
In the current studies, we investigated hypoxia-induced gene expression in human retinal pericytes and found that expression of CHL-1, a member of the bone morphogenetic protein (BMP) superfamily, is upregulated by hypoxia. We investigated regulation of CHL-1 expression and the ability of CHL-1 to antagonize the antiangiogenic properties of BMP-4 using a human cell-based angiogenesis assay.
RESULTS:
We report that hypoxia induced hypoxia inducible factor-1alpha-driven expression of CHL-1. Both CHL-1 and BMP-4 were secreted from human retinal pericytes. We found that CHL-1 complexes with BMP-4 to antagonize the antiangiogenic effects of BMP-4, and that BMP-4 and vascular endothelial growth factor (VEGF) co-regulate angiogenesis.
CONCLUSIONS:
We propose that hypoxia-induced upregulation of CHL-1 alters the homeostatic balance between BMP-4 and VEGF to synergize with VEGF in driving retinal angiogenesis.
AuthorsRosemary Kane, Catherine Godson, Colm O'Brien
JournalMolecular vision (Mol Vis) Vol. 14 Pg. 1138-48 (Jun 20 2008) ISSN: 1090-0535 [Electronic] United States
PMID18587495 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • BMP4 protein, human
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Proteins
  • CHRDL1 protein, human
  • Eye Proteins
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Nerve Tissue Proteins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Proteins (antagonists & inhibitors, pharmacology)
  • Cell Hypoxia (drug effects)
  • Cells, Cultured
  • Eye Proteins (genetics, metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Molecular Sequence Data
  • Neovascularization, Physiologic (drug effects)
  • Nerve Tissue Proteins (genetics, metabolism)
  • Pericytes (cytology, drug effects, metabolism)
  • Protein Binding (drug effects)
  • Reproducibility of Results
  • Retina (cytology, drug effects, metabolism)
  • Transcriptional Activation (drug effects)
  • Up-Regulation (drug effects)
  • Vascular Endothelial Growth Factor A (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: